SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-24-102956
Filing Date
2024-04-19
Accepted
2024-04-19 16:31:27
Documents
2
Group Members
CRG PARTNERS III (CAYMAN) LEV AIV I L.P.CRG PARTNERS III (CAYMAN) UNLEV AIV I L.P.CRG PARTNERS III - PARALLEL FUND A L.P.CRG PARTNERS III L.P.CRG PARTNERS III PARALLEL FUND B (CAYMAN) L.P.NATHAN D. HUKILL

Document Format Files

Seq Description Document Type Size
1 SC 13D d830497dsc13d.htm SC 13D 131073
2 EX-99.1 d830497dex991.htm EX-99.1 4776
  Complete submission text file 0001193125-24-102956.txt   137796
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Subject) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88541 | Film No.: 24858233
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 1000 MAIN STREET, SUITE 2500 HOUSTON TX 77002
Business Address 1000 MAIN STREET, SUITE 2500 HOUSTON TX 77002 713-209-7350
CR Group L.P. (Filed by) CIK: 0001702352 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D